• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC DE COSTA RICA S.R.L. POLARX; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC DE COSTA RICA S.R.L. POLARX; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Lot Number 0031776980
Device Problem Device Contamination with Body Fluid (2317)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/12/2023
Event Type  malfunction  
Manufacturer Narrative
The device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.
 
Event Description
It was reported that during an atrial fibrillation procedure a polarx balloon catheter was selected for use.When the physician tried to inflate balloon in the left inferior pulmonary vein (lipv) a blood detection error (error 1-00004000-2) occurred.Blood was visible within the balloon.The device was replaced and the procedure was completed successfully.No patient complications were reported.The device is expected to return for laboratory analysis.
 
Manufacturer Narrative
Polarx balloon catheter st was evaluated by boston scientific.Visual inspection noted that there was visible blood was seen inside the balloon and no external damage was noted.The device was not assessed with an isaac pressure decay testing system to determine if any potential leak paths existed that may have contributed to the blood detection error in the field, as there was visible blood inside the balloon region.The catheter handle was opened to further investigate the breach leading to the blood inside the balloon.No leaks were observed, but it was noticed that blood was only visible in the inner balloon.The blood in the inner balloon is believed to be caused by a short guidewire lumen braid termination which was found to be out of specification.
 
Event Description
It was reported that during an atrial fibrillation procedure a crbs polarx balloon catheter st was selected for use.A blood detection error has occurred.The device was replaced and the procedure was completed successfully.No patient complications were reported.The device has been received at boston scientific post market laboratory.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POLARX
Type of Device
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
BOSTON SCIENTIFIC DE COSTA RICA S.R.L.
302 parkway
global park, la aurora
heredia
CS 
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
302 parkway, global park
la aurora - heredia
CS  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key18386713
MDR Text Key331497182
Report Number2124215-2023-73153
Device Sequence Number1
Product Code OAE
Combination Product (y/n)N
Reporter Country CodeKS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/18/2024
Device Lot Number0031776980
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/12/2023
Initial Date FDA Received12/22/2023
Supplement Dates Manufacturer Received02/28/2024
Supplement Dates FDA Received03/22/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/08/2023
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-